The partners at Finley & Figg often refer to themselves as a “boutique law firm.” Boutique, as in chic, selective, and prosperous. Oscar Finley and Wally Figg are none of these things. They are a two-bit operation of ambulance chasers who bicker like an old married couple. Until change comes their way—or, more accurately, stumbles in. After leaving a fast-track career and going on a serious bender, David Zinc is sober, unemployed, and desperate enough to take a job at Finley & Figg. Now the firm is ready to tackle a case that could make the partners rich—without requiring them to actually practice much law. A class action suit has been brought against Varrick Labs, a pharmaceutical giant with annual sales of $25 billion, alleging that Krayoxx, its most popular drug, causes heart attacks. Wally smells money. All Finley & Figg has to do is find a handful of Krayoxx users to join the suit. It almost seems too good to be true . . . and it is.